NEDD4 and central nervous system cancer: The higher the grade of gliomas, the higher the level of NEDD4-1 expression (nontumorous=16.15±1.50%, low grade=40.32 ±4.01%, high grade=66.70± 5.44%, P<0.01, respectively, Figure 6G-6I).